albendazole has been researched along with Idiopathic Parkinson Disease in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was a good response to levodopa therapy as well as cysticidal therapy with albendazole, allowing later reduction of levodopa dosage in one patient and complete withdrawal in the other." | 2.71 | Parkinsonism associated with neurocysticercosis. ( Sá, DS; Teive, HA; Troiano, AR; Werneck, LC, 2005) |
| "Rotenone (1." | 1.51 | Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease. ( Abd El Fattah, MA; Ahmed, LA; El-Sayeh, BM; Kandil, EA; Sayed, RH, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandil, EA | 1 |
| Sayed, RH | 1 |
| Ahmed, LA | 1 |
| Abd El Fattah, MA | 1 |
| El-Sayeh, BM | 1 |
| Sá, DS | 1 |
| Teive, HA | 1 |
| Troiano, AR | 1 |
| Werneck, LC | 1 |
1 trial available for albendazole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Parkinsonism associated with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Antiparkinson Agents; Brain; Female; Humans; Levodopa; Magnetic R | 2005 |
1 other study available for albendazole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Topics: Albendazole; Animals; Behavior, Animal; Cell Death; Cell Survival; Disease Models, Animal; Dopaminer | 2019 |